BioAesthetics: Funding, Investors & Team (Sep 2026)
BioAesthetics was founded in 2015 as a Tulane University spin-out with the mission to improve reconstruction options for breast cancer patients after they undergo mastectomies. The BioAesthetics’ initial product is a tissue-engineered nipple-areolar complex (NAC). This product will be provided to plastic and reconstructive surgeons as an off-the-shelf ready, acellular, NAC graft. During the breast reconstruction phase, after a mastectomy, the surgeon would engraft the NAC graft in position onto the patient’s reconstructed breast. The patient’s body would then use this NAC graft as a building frame to regenerate their own NAC. This patent-pending product is currently in the pre-clinical phase.
BioAesthetics has raised $300k across 1 funding round on record, the most recent a Grant of $300k announced in Jan 2021.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
BioAesthetics Company Profile and Key Stats
Latest funding round on record: Jan 2021.
BioAesthetics Funding Rounds
BioAesthetics Founders and Leadership Team
Contact details for the BioAesthetics team: 1 of 1 has an email address on file.
Start 14-day free trial →BioAesthetics Funding Compared to Other Biotechnology Startups
BioAesthetics' latest round of $300k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like BioAesthetics in Biotechnology and New Orleans
Companies Similar to BioAesthetics
SeqWell’s is a biotechnology company that specializes in the fields of gene sequencing and laboratory…
DermaSensor’s mission is to save lives and healthcare costs by providing easy access to effective skin cancer…
Solstice Oncology is a clinical stage immuno-oncology company
Encoded Therapeutics is a developer of precision gene therapies intended to provide treatment for a broad…
BrainChild Bio is a biotechnology company in the clinical stage that specializes in pediatric brain tumors.…
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
BioAesthetics Funding FAQs
What does BioAesthetics do?
BioAesthetics was founded in 2015 as a Tulane University spin-out with the mission to improve reconstruction options for breast cancer patients after they undergo mastectomies. The BioAesthetics’ initial product is a tissue-engineered nipple-areolar complex (NAC). This product will be provided to plastic and reconstructive surgeons as an off-the-shelf ready, acellular, NAC graft. During the breast reconstruction phase, after a mastectomy, the surgeon would engraft the NAC graft in position onto the patient’s reconstructed breast. The patient’s body would then use this NAC graft as a building frame to regenerate their own NAC. This patent-pending product is currently in the pre-clinical phase.
How much funding has BioAesthetics raised?
BioAesthetics has raised $300k across 1 round on record. The most recent is a Grant of $300k announced in Jan 2021.
When did BioAesthetics last raise funding?
BioAesthetics' most recent funding round on record is a Grant of $300k, announced in Jan 2021.
Who is the CEO of BioAesthetics?
Nicholas Pashos is listed as CEO at BioAesthetics.
Where is BioAesthetics headquartered?
BioAesthetics is based in New Orleans, Louisiana, United States.
How many employees does BioAesthetics have?
BioAesthetics is in the 1-10 employee band.
How does BioAesthetics' funding compare to other Biotechnology startups?
BioAesthetics' latest round of $300k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,183 tracked companies over the last two years.
About FundedIQ's BioAesthetics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for BioAesthetics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.